|
McLean, VA - October 18, 2005 -
immixGroupsm, Inc., a leading government business consulting and
channel management company, today announced that the immixGroup Board of
Advisors has raised $60,000 for the Johns Hopkins Sidney Kimmel Cancer
Center. The check was presented at a reception following the 2005 immixGroup
Board of Advisors Johns Hopkins Colon Cancer Center 2005 Charity Golf
Tournament on Monday, October 17 at Lansdowne Golf Resort in Lansdowne,
Virginia.
This year's fundraiser was made
possible in large part through the generosity of its sponsors, which
include:
The American Cancer Society estimates that about 145,290 new cases of
colorectal cancer will be diagnosed in 2005, which averages to about 400 per
day or one every 4 minutes. Colorectal cancer is the third most common
cancer diagnosed among Americans. The collaborative efforts of the
clinicians and researchers at Johns Hopkins Sidney Kimmel Cancer Center have
led to many advances in the early detection and treatment of colon and
rectal cancer. These endeavors promise to translate into better treatment
outcomes for all patients.
"From the creation of this event, our mission was to bring together
organizations, friends and supporters to help raise capital and awareness
for a very worthy cause," said Jeff Copeland, president and CEO of
immixGroup, Inc. "It is with great appreciation that we thank the
tournament's sponsors, players, volunteers and members of the executive
planning committee for their overwhelming generosity and support to make
this event a success."
"The Johns Hopkins Colon Cancer Center is a multidisciplinary program
providing comprehensive diagnostic testing and multidisciplinary
consultation services for patients diagnosed with cancer of the large bowel
and those at high risk for developing cancer of the colon and rectum," said
Michael A. Choti, MD at the Johns Hopkins Colon Cancer Center. "The
generosity of immixGroup, its Board of Advisors, and the sponsors and
participants in this event helps meet the financial needs of our center so
we can focus our attention on research and patient education. With the help
of this generous contribution, the message that colorectal cancer is
preventable, treatable, and beatable, will be realized."
immixGroup also announced the date for the 2006 Board of Advisors Johns
Hopkins Colon Cancer Center Charity Golf Tournament, which is October 16,
2006.
About immixGroup, Inc.
Founded in 1997 and headquartered in McLean, VA, immixGroup, Inc. helps
enterprise technology companies sell more effectively to the government.
Together with its immixTechnologysm subsidiary, the company
provides contract management and outsourcing, channel management, business
development, sales training, and executive recruiting services to its
clients. Attracting more than 160 clients from startups to leading companies
such as IBM, Juniper Networks, and Symantec, immixGroup is one of the
fastest growing companies in the industry. For more information, contact
immixGroup, Inc. at 703-752-0610, via e-mail at
info@immixgroup.com or on the Web at
www.immixgroup.com. immixGroup is a service
marks of immixGroup, Inc.
Colorectal cancer is the second leading cause of cancer death in the United
States and the third most commonly diagnosed cancer.
The
American Cancer Society estimates that about 145,290 new cases of colorectal
cancer will be diagnosed in 2005.
A personal or family history of colon and/or rectum cancer or polyps and
inflammatory bowel disease have been associated with an increased risk for
this type of cancer. Other risk factors include physical inactivity,
high-fat and/or low-fiber diet, and an inadequate intake of fruits and
vegetables.
Colorectal cancer is preventable if a polyp is removed before it turns into
cancer. The best way to prevent colorectal cancer is to get screened by
having a colonoscopy. Furthermore, colorectal cancer is treatable and
beatable if it's caught in its' early stages.
The collaborative efforts of the clinicians and researchers at Johns Hopkins
Sidney Kimmel Cancer Center have led to many advances in the early detection
and treatment of colon and rectal cancer. These endeavors promise to
translate into better treatment outcomes for all patients.
For more information about colorectal cancer, including statistics,
diagnosis and treatment, visit:
www.hopkinskimmelcancercenter.org/kpr/colon-homepage.cfm
www.ccalliance.org
www.coloncancerfoundation.org
www.cancer.org
|
Steve Toole,
VP of Sales and
Marketing,
IMMIX Group
 |
